ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,086.53
1.01%
Dow Jones
38,297.82
1.27%
US Dollar vs MXN
17.01561
-0.80%
Brent Oil
83.635
-2.63%
Bitcoin
58,524.77
-3.39%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) Noticias

HROW Harrow Inc

10.565
0.375 (3.68%)
Última actualización: 13:56:44
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Harrow Inc HROW NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.375 3.68% 10.565 13:56:44
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
10.24 10.04 10.81 10.19
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:00BWHarrow Will Release First Quarter 2024 Financial Results..
02/4/202407:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
20/3/202406:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
19/3/202416:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
19/3/202406:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
06/3/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202406:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
21/2/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202418:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:15EDGAR2Form 8-K - Current report
15/2/202415:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
09/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202415:30EDGAR2Form 8-K - Current report
29/1/202414:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202406:00BWHarrow Announces New Appointments to its Board of Directors
11/1/202406:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
09/1/202409:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202407:00EDGAR2Form 8-K - Current report
03/1/202406:15BWMelt Pharmaceuticals Provides Corporate Update
03/1/202406:00BWHarrow Partners with Leading Healthcare Market Access..
29/11/202306:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
20/11/202306:00BWHarrow to Present at Two Investor Conferences in November
16/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:34EDGAR2Form 8-K - Current report
13/11/202315:01BWHarrow Announces Third Quarter 2023 Financial Results
03/11/202315:52EDGAR2Form 8-K - Current report
30/10/202307:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
24/10/202306:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
29/9/202315:01EDGAR2Form 8-K - Current report
29/9/202307:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
26/9/202307:00BWMelt Pharmaceuticals Announces Exclusive Development and..
20/9/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:05EDGAR2Form 8-K - Current report
09/8/202315:01BWHarrow Announces Second Quarter 2023 Financial Results
31/7/202306:00BWHarrow Launches VIGAMOX® in the U.S.
26/7/202308:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
21/7/202315:02EDGAR2Form 8-K - Current report
20/7/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202318:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202306:00BWHarrow Prices $60 Million Public Offering of Common Stock
18/7/202321:55BWHarrow erwirbt US-amerikanische und kanadische..
18/7/202316:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202316:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
18/7/202315:59EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
HROW
Harrow
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados